In breast cancer, inhibition of c-Myc decreases translation and transcription of GLUT1 and inhibits growth of tumor cells (Chen et al., 2011; Hiscox & Nicholson, 2008; Jain et al., 2015). The gene discussed is SLC2A1; the disease is neoplasm.